2,861 research outputs found

    Hybrid multimode resonators based on grating-assisted counter-directional couplers

    Get PDF
    FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESPResearch thrusts in silicon photonics are developing control operations using higher order waveguide modes for next generation high-bandwidth communication systems. In this context, devices allowing optical processing of multiple waveguide modes can reduce architecture complexity and enable flexible on-chip networks. We propose and demonstrate a hybrid resonator dually resonant at the 1st and 2nd order modes of a silicon waveguide. We observe 8 dB extinction ratio and modal conversion range of 20 nm for the 1st order quasi-TE mode input.25141648416490FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESPFUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESP2015/20525-6Office of Naval Research (ONR) Multi-Disciplinary Research Initiative; National Science Foundation (NSF) (NNCI-SDNI, ERC CIAN); Defense Advanced Research Projects Agency (DARPA); Army Research Office (ARO); Cymer Corporation. M. Souza acknowledges FAPESP (grant 2015/20525-6)

    A Reference Architecture for Management of Security Operations in Digital Service Chains

    Get PDF
    Modern computing paradigms (i.e., cloud, edge, Internet of Things) and ubiquitous connectivity have brought the notion of pervasive computing to an unforeseeable level, which boosts service-oriented architectures and microservices patterns to create digital services with data-centric models. However, the resulting agility in service creation and management has not been followed by a similar evolution in cybersecurity patterns, which still largely rest on more conventional device- and infrastructure-centric models. In this Chapter, we describe the implementation of the GUARD Platform, which represents the core element of a modern cybersecurity framework for building detection and analytics services for complex digital service chains. We briefly review the logical components and how they address scientific and technological challenges behind the limitations of existing cybersecurity tools. We also provide validation and performance analysis that show the feasibility and efficiency of our implementation

    Spatial patterns and scale freedom in a Prisoner's Dilemma cellular automata with Pavlovian strategies

    Full text link
    A cellular automaton in which cells represent agents playing the Prisoner's Dilemma (PD) game following the simple "win-stay, loose-shift" strategy is studied. Individuals with binary behavior, such as they can either cooperate (C) or defect (D), play repeatedly with their neighbors (Von Neumann's and Moore's neighborhoods). Their utilities in each round of the game are given by a rescaled payoff matrix described by a single parameter Tau, which measures the ratio of 'temptation to defect' to 'reward for cooperation'. Depending on the region of the parameter space Tau, the system self-organizes - after a transient - into dynamical equilibrium states characterized by different definite fractions of C agents (2 states for the Von Neumann neighborhood and 4 for Moore neighborhood). For some ranges of Tau the cluster size distributions, the power spectrums P(f) and the perimeter-area curves follow power-law scalings. Percolation below threshold is also found for D agent clusters. We also analyze the asynchronous dynamics version of this model and compare results.Comment: Accepted for publication in JSTA

    Biophysical and biochemical characterization of a liposarcoma-derived recombinant MnSOD protein acting as an anticancer agent

    Get PDF
    A recombinant MnSOD (rMnSOD) synthesized by specific cDNA clones derived from a liposarcoma cell line was shown to have the same sequence as the wild-type MnSOD expressed in the human myeloid leukaemia cell line U937, except for the presence of the leader peptide at the N-terminus. These results were fully confirmed by the molecular mass of rMnSOD as evaluated by ES/MS analysis (26662.7 Da) and the nucleotide sequence of the MnSOD cDNA. The role of the leader peptide in rMnSOD was investigated using a fluorescent and/or 68Gallium-labelled synthetic peptide. The labelled peptide permeated MCF-7 cells and uptake could be inhibited in the presence of an excess of oestrogen. In vivo it was taken up by the tumour, suggesting that the molecule can be used for both therapy and diagnosis. The in vitro and in vivo pharmacology tests confirmed that rMnSOD is only oncotoxic for tumour cells expressing oestrogen receptors. Pharmacokinetic studies in animals performed with 125I- and 131I-labelled proteins confirmed that, when administered systemically, rMnSOD selectively reached the tumour, where its presence was unambiguously demonstrated by scintigraphic and PET scans. PCR analysis revealed that Bax gene expression was increased and the Bcl2 gene was down regulated in MCF7 cells treated with rMnSOD, which suggests that the protein induces a pro-apoptotic mechanism

    Novel anti-inflammatory and chondroprotective effects of the human melanocortin MC1 receptor agonist BMS-470539 dihydrochloride and human melanocortin MC3 receptor agonist PG-990 on lipopolysaccharide activated chondrocytes

    Get PDF
    Human melanocortin MC1 and MC3 receptors expressed on C-20/A4 chondrocytes exhibit chondroprotective and anti-inflammatory effects when activated by melanocortin peptides. Nearly 9 million people in the UK suffer from osteoarthritis, and bacterial infections play a role in its development. Here, we evaluate the effect of a panel of melanocortin peptides with different selectivity for human melanocortin MC1 (α-MSH, BMS-470539 dihydrochloride) and MC3 ([DTrp8]-γ-MSH, PG-990) receptors and C-terminal peptide α-MSH11-13(KPV), on inhibiting LPS-induced chondrocyte death, pro-inflammatory mediators and induction of anti-inflammatory proteins. C-20/A4 chondrocytes were treated with a panel of melanocortin peptides prophylactically and therapeutically in presence of LPS (0.1 μg/ml). The chondroprotective properties of these peptides determined by cell viability assay, RT-PCR, ELISA for detection of changes in inflammatory markers (IL-6, IL-8 and MMP-1, -3 and -13) and western blotting for expression of the anti-inflammatory protein heme-oxygenase-1. C-20/A4 expressed human melanocortin MC1 and MC3 receptors and melanocortin peptides elevated cAMP. LPS stimulation caused a reduction in C-20/A4 viability, attenuated by the human melanocortin MC1 receptor agonist BMS-470539 dihydrochloride, and MC3 receptor agonists PG-990 and [DTrp8]-γ-MSH. Prophylactic and therapeutic regimes of [DTrp8]-γ-MSH significantly inhibited LPS-induced modulation of cartilage-damaging IL-6, IL-8, MMPs −1,-3 and −13 mediators both prophylactically and therapeutically, whilst human melanocortin MC1 and MC3 receptor agonists promoted an increase in HO-1 production. In the presence of LPS, activation of human melanocortin MC1 and MC3 receptors provided potent chondroprotection, upregulation of anti-inflammatory proteins and downregulation of inflammatory and proteolytic mediators involved in cartilage degradation, suggesting a new avenue for osteoarthritis treatment

    Stuck in the slow lane: reconceptualising the links between gender, transport and social exclusion

    Get PDF
    This article draws upon primary research undertaken with over 3,000 women in the North East of England to explore the links between women, transport and the labour market. The research, funded by the ESF, advances the idea of spatiality as a social construction and builds on seminal studies relating to women and poverty to consider the way in which a gender division of transport constrains women's mobility and restricts their employment opportunities. It is likely to contribute to important debates, concerning strategies to tackle worklessness and the most effective spatial level at which to configure public transport networks

    Cooperation and Self-Regulation in a Model of Agents Playing Different Games

    Full text link
    A simple model for cooperation between "selfish" agents, which play an extended version of the Prisoner's Dilemma(PD) game, in which they use arbitrary payoffs, is presented and studied. A continuous variable, representing the probability of cooperation, pk(t)∈p_k(t) \in [0,1], is assigned to each agent kk at time tt. At each time step tt a pair of agents, chosen at random, interact by playing the game. The players update their pk(t)p_k(t) using a criteria based on the comparison of their utilities with the simplest estimate for expected income. The agents have no memory and use strategies not based on direct reciprocity nor 'tags'. Depending on the payoff matrix, the systems self-organizes - after a transient - into stationary states characterized by their average probability of cooperation pˉeq\bar{p}_{eq} and average equilibrium per-capita-income pˉeq,Uˉ∞\bar{p}_{eq},\bar{U}_\infty. It turns out that the model exhibit some results that contradict the intuition. In particular, some games which - {\it a priory}- seems to favor defection most, may produce a relatively high degree of cooperation. Conversely, other games, which one would bet that lead to maximum cooperation, indeed are not the optimal for producing cooperation.Comment: 11 pages, 3 figures, keybords: Complex adaptive systems, Agent-based models, Social system

    Complement Activation Determines the Therapeutic Activity of Rituximab In Vivo

    Get PDF
    Rituximab is an anti-CD20 chimeric mAb effective for the treatment of B-NHL. It can lyse lymphoma cells in vitro through both C- and Ab-dependent cellular cytotoxicity. The mechanism of action of rituximab in vivo is however still unclear. We have set up a new in vivo model in nonimmunodeficient mice by stable transduction of the human CD20 cDNA in the murine lymphoma line EL4. Animals injected i.v. with the EL4-CD20+ lymphoma cells died within 30 days with evident liver, spleen, and bone marrow involvement, confirmed by immunohistochemistry and PCR analysis. A single injection of rituximab or the murine anti-CD20 Ab 1F5, given i.p. 1 day after the tumor, cured 100% of the animals. Indeed, at week 4 after tumor cell inoculation, CD20+ cells were undetectable in all organs analyzed in rituximab-treated animals, as determined by immunohistochemistry and PCR. Rituximab had no direct effect on tumor growth in vitro. Depletion of either NK cells or neutrophils or both in tumor-injected animals did not affect the therapeutic activity of the drug. Similarly, rituximab was able to eradicate tumor cells in athymic nude mice, suggesting that its activity is T cell independent. In contrast, the protective activity of rituximab or the 1F5 Ab was completely abolished in syngeneic knockout animals lacking C1q, the first component of the classical pathway of C (C1qa−/−). These data demonstrate that C activation is fundamental for rituximab therapeutic activity in vivo
    • …
    corecore